investment analyst coverage
Craig-Hallum Initiates Coverage of Guardant Health With Buy Rating
The investment bank focused mainly on its expectations for Guardant's colorectal cancer screening assay, but also argued its overall business is poised for significant growth.
Craig-Hallum Downgrades Exact Sciences to Hold, Lowers Price Target to $35
Analysts for the bank cited expected competition from Guardant Health's blood-based colorectal cancer test, as well as market challenges for Exact's Cologuard.
UBS Initiates Coverage on QuidelOrtho, Waters, PerkinElmer, Hologic, Agilent Technologies
The investment bank also released an updated rating for Danaher as it expanded its coverage of the life science tools and diagnostic market.
BTIG Initiates Coverage of Cue Health With Buy Rating
The investment bank said the company is well positioned to take shares from reference labs and other point-of-care testing companies.
William Blair, Cowen Initiate Coverage of Sera Prognostics With Outperform Rating
Both banks highlighted the market potential of Sera's preterm birth risk test and pipeline products but warned of the company's early stage.